3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
56
Ovarian Neoplasms
35
Carcinoma, Hepatocellular
35
Neoplasms
25
Fallopian Tube Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Endometrial Neoplasms
13
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Colonic Neoplasms
9
Lung Neoplasms
8
Uterine Cervical Neoplasms
7
Liver Neoplasms
7
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Stomach Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
24
blinatumomab
20
fludarabine phosphate
19
Dexamethasone
19
Vincristine
18
Whole-Body Irradiation
16
Specimen Handling
16
Cytarabine
16
Tacrolimus
14
Mycophenolic Acid
14
Peripheral Blood Stem Cell Transplantation
13
Melphalan
13
Mercaptopurine
12
Calcium Dobesilate
12
merphos
11
Busulfan
11
Biopsy
11
Magnetic Resonance Spectroscopy
10
Etoposide
10
Stem Cell Transplantation
9
Prednisone
9
Granulocyte Colony-Stimulating Factor
9
Cyclosporine
9
Thiotepa
8
Rituximab
8
Mesna
8
Filgrastim
8
Doxorubicin
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Bevacizumab
×
90 days
×
Clear all
No trials found.